Daniel Van Den Bergh

Daniel Van Den Bergh Email and Phone Number

Kaiser Permanente Ventures @ Kaiser Permanente Ventures
Daniel Van Den Bergh's Location
San Francisco Bay Area, United States, United States
Daniel Van Den Bergh's Contact Details

Daniel Van Den Bergh work email

Daniel Van Den Bergh personal email

Daniel Van Den Bergh phone numbers

About Daniel Van Den Bergh

Healthcare technology venture capital investor at Endeavour Vision

Daniel Van Den Bergh's Current Company Details
Kaiser Permanente Ventures

Kaiser Permanente Ventures

View
Kaiser Permanente Ventures
Daniel Van Den Bergh Work Experience Details
  • Kaiser Permanente Ventures
    Senior Investment Director
    Kaiser Permanente Ventures 2024 - Present
    Oakland, California, Us
    KP Ventures is the strategic venture capital fund of Kaiser Permanente. It invests in and supports transformative healthcare technology companies that align with the Kaiser Permanente care model. KP Ventures was founded in 1997 and has raised $770M across six funds and is currently deploying out of its $220M Fund VI.Investment work: NOCD, Ordr, Nuvolo (acquired), Vesta Healthcare, NextHealth (acquired), Protenus, Talix (acquired), Collective Medical (acquired).
  • Kaiser Permanente Ventures
    --
    Kaiser Permanente Ventures 2022 - 2024
    Oakland, California, Us
  • Kaiser Permanente Ventures
    Investment Director
    Kaiser Permanente Ventures 2021 - 2022
    Oakland, California, Us
  • Kaiser Permanente Ventures
    Principal
    Kaiser Permanente Ventures 2019 - 2021
    Oakland, California, Us
  • Kaiser Permanente Ventures
    Senior Associate
    Kaiser Permanente Ventures 2017 - 2019
    Oakland, California, Us
  • Endeavour Vision
    Senior Investment Director, Us Digital Health Practice Lead
    Endeavour Vision Jan 2022 - Dec 2024
    Geneva, Ch
    Endeavour Vision is a transatlantic venture capital firm that invests in medical devices and digital health. Built and led the firm's US digital health strategy and invested from it.
  • Healthjoy
    Investment Lead, Board Observer
    Healthjoy 2022 - 2024
    Chicago, Il, Us
  • Nocd
    Investment Lead, Board Observer
    Nocd 2021 - 2022
    Chicago, Il, Us
  • Ordr Inc.
    Investment Lead, Board Observer
    Ordr Inc. 2020 - 2022
    Santa Clara, Ca
  • Nuvolo
    Investment Team, Board Director
    Nuvolo 2019 - 2022
    Wellesley , Massachusetts, Us
    Acquired by Trane Technologies in 2023
  • Vesta Healthcare
    Investment Team
    Vesta Healthcare 2019 - 2022
    New York, Ny, Us
  • Nexthealth Technologies
    Investment Team
    Nexthealth Technologies 2019 - 2022
    Denver, Colorado, Us
    Acquired by Softheon in 2022
  • Protenus
    Investment Team, Board Director
    Protenus 2017 - 2022
    Baltimore, Maryland, Us
  • Talix
    Investment Team, Board Observer
    Talix 2018 - 2021
    Acquired by Edifecs in 2021
  • Collective Medical
    Investment Team
    Collective Medical 2017 - 2020
    Acquired by PointClickCare for $650M in 2020
  • Lumiata
    Director, Strategy & Operations
    Lumiata 2016 - 2017
    San Mateo, California, Us
    Clinical analytics saas platform, backed by Intel Capital, Khosla Ventures, and Sandbox Industries, which predicts and stratifies health risks of populations. Acquired by Somatus in 2022.
  • Lumiata
    Head Of Projects
    Lumiata 2015 - 2016
    San Mateo, California, Us
  • Longitude Capital
    Mba Associate
    Longitude Capital 2014 - 2014
    Menlo Park, Ca, Us
    Venture capital internship focused on developing the firm's HCIT & Tech-Enabled Services thesis and initial deal flow. Sourced live investment processes from the initiative, including Lumiata (clinical analytics) which I joined after graduation.
  • Safeguard Scientifics
    Associate, Healthcare Venture Capital
    Safeguard Scientifics 2011 - 2013
    Radnor, Pennsylvania, Us
    Venture capital investing in healthcare IT, medical devices, diagnostics, and specialty pharmaceuticals. Founded in 1953, Safeguard is one of the country's oldest venture capital firms; it deploys out of an evergreen fund structure.Involved in: - Putney (acquired by Dechra Pharmaceuticals)- NuPathe (acquired by Teva Pharmaceuticals)- QuantiaMD (acquired by Physicians Interactive)- Sotera Wireless (exited via secondary sale)- Alverix (acquired by Becton Dickinson)- Advanced Biohealing (acquired by Shire Pharmaceuticals)
  • Ec Mergers & Acquisitions
    Associate, Healthcare M&A
    Ec Mergers & Acquisitions 2010 - 2011
    New York, Ny, Us
    Specialty investment bank focused on EU/US cross-border mergers and acquisitions.
  • Ec Mergers & Acquisitions
    Senior Analyst, Healthcare M&A
    Ec Mergers & Acquisitions 2009 - 2010
    New York, Ny, Us
  • Citigroup Global Markets
    Analyst, Healthcare Investment Banking
    Citigroup Global Markets 2007 - 2009
    New York, New York, Us
    Mergers, acquisitions, leveraged buyouts, and equity offerings; London ('07-'08) and New York ('08-'09).
  • Lux Capital
    Summer Analyst
    Lux Capital 2006 - 2006
    New York, Ny, Us
    Venture capital internship focused on early-stage life sciences investing.

Daniel Van Den Bergh Skills

Clinical Trials Mergers Corporate Finance Valuation Software As A Service Financial Modeling Investments Biotechnology Healthcare Life Sciences Diagnostics Medical Devices Strategy Lifesciences Emerging Growth Companies Healthcare It Healthcare Information Technology Growth Capital M&a Experience Private Equity Investment Banking Due Diligence Pharmaceutical Industry Private Equity/venture Capital Corporate Development Venture Capital Digital Health Mergers And Acquisitions

Daniel Van Den Bergh Education Details

  • The Wharton School
    The Wharton School
    Health Care Management & Entrepreneurial Management
  • Cornell University
    Cornell University
    Biological Engineering & Applied Economics

Frequently Asked Questions about Daniel Van Den Bergh

What company does Daniel Van Den Bergh work for?

Daniel Van Den Bergh works for Kaiser Permanente Ventures

What is Daniel Van Den Bergh's role at the current company?

Daniel Van Den Bergh's current role is Kaiser Permanente Ventures.

What is Daniel Van Den Bergh's email address?

Daniel Van Den Bergh's email address is daniel.vandenbergh@kp.org

What is Daniel Van Den Bergh's direct phone number?

Daniel Van Den Bergh's direct phone number is (650) 235*****

What schools did Daniel Van Den Bergh attend?

Daniel Van Den Bergh attended The Wharton School, Cornell University.

What skills is Daniel Van Den Bergh known for?

Daniel Van Den Bergh has skills like Clinical Trials, Mergers, Corporate Finance, Valuation, Software As A Service, Financial Modeling, Investments, Biotechnology, Healthcare, Life Sciences, Diagnostics, Medical Devices.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.